Sponsor

Merrimack Pharmaceuticals

Clinical research sponsor

Published trials15
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

15 shown
A Study Evaluating MM-310 in Patients With Solid TumorsNCT03076372 · lead sponsor · 2017-02-22
UNKNOWN
Phase 1 Combination Study of MM-151 With MM-121, MM-141, or TrametinibNCT02538627 · lead sponsor · 2015-08-01
TERMINATED
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer PatientsNCT02213744 · lead sponsor · 2014-07-01
TERMINATED
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary TreatmentNCT01520389 · lead sponsor · 2012-01-01
COMPLETED
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced CancersNCT01451632 · lead sponsor · 2011-10-01
COMPLETED
A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast CancerNCT01421472 · lead sponsor · 2011-08-01
COMPLETED
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast CancerNCT01304797 · lead sponsor · 2011-03-01
UNKNOWN
A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast CancersNCT01209195 · lead sponsor · 2010-10-01
COMPLETED
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast CancerNCT01151046 · lead sponsor · 2010-06-01
COMPLETED
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast CancerNCT01097460 · lead sponsor · 2010-04-01
COMPLETED
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung CancerNCT00994123 · lead sponsor · 2010-02-01
COMPLETED
A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive CancersNCT00911898 · lead sponsor · 2009-06-01
COMPLETED
A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid ArthritisNCT00458146 · lead sponsor · 2007-02-01
COMPLETED
Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)NCT00105976 · lead sponsor · 2005-02-01
COMPLETED
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLCNCT02387216 · collaborator · 2015-02-01
TERMINATED

Sponsor roles

lead sponsor14
collaborator1

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.